Dáil Éireann Debate, Tuesday - 20 February 2024
555. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 362 of 1 February 2024, if he believes that transgender patients are allowed to choose to access care under models of care other than that of the National Gender Service. [7655/24]
Amharc ar fhreagra556. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 364 of 1 February 2024, if the National Gender Service can explain exactly how the assessment quality can be compromised by being virtual, and if they have ever offered virtual assessments. [7656/24]
Amharc ar fhreagra558. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 366 of 1 February 2024, if thromboembolic and liver disease are not a risk of elevated testosterone levels, how has this information persisted across all four versions of the National Gender Service’s Endocrinology NCHD Induction document. [7658/24]
Amharc ar fhreagra559. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 367 of 1 February 2024, if hormone concentrations can guide treatment decisions and the reason the NGS recommend GPs not to monitor them. [7659/24]
Amharc ar fhreagra561. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 373 of 1 February 2024, the details of the National Gender Service’s outstanding business cases and the calculations that demonstrate these will reduce the waiting list to months. [7661/24]
Amharc ar fhreagra562. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 373 of 1 February 2024, if any patient of the National Gender Service has ever been turned away due to their lack of employment and its impact on their occupational functioning. [7662/24]
Amharc ar fhreagraI propose to take Questions Nos. 555, 556, 558, 559, 561 and 562 together.
As this is a service matter I have referred the question to the HSE for direct reply to the Deputy.
